Founded Year

2015

Stage

Series C | Alive

Total Raised

$150.1M

Last Raised

$105M | 1 yr ago

About Truvian Sciences

Truvian Sciences is a healthcare company at the intersection of diagnostics and consumer technology. Its automated benchtop system produces lab-accurate results for a full suite of health tests using a small sample of blood. Powered by patented technologies and intelligent integration, Truvian's system delivers an alternative to off-site labs, providing immediate insights to inform healthcare decisions.

Truvian Sciences Headquarter Location

10300 Campus Point Drive, Suite 190

San Diego, California, 92121,

United States

858-480-2400

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Truvian Sciences's Products & Differentiation

See Truvian Sciences's products and how their products differentiate from alternatives and competitors

  • We are not revealing the name yet and will call it our core technology for now

    Truvian’s compact instrument will deliver a convenient and affordable alternative to offsite laboratories, providing lab-accurate rapid insights to inform healthcare decisions. The groundbreaking diagnostic platform combines clinical chemistry, immunoassay, and hematology simultaneously within one instrument.

    Differentiation

    Three modalities in a single run with a turn around time in 20 minutes for an entire health panel 

  • Subscribe to see more

    We're on a mission to enable every organization to make smarter decisions about tech. Whether it's finding a new game-changing vendor or understanding a new market, it's easier, faster and smarter with CB Insights. All made possible by the smartest, hardest-working team in tech. Subscribe to see more.

    Differentiation

    We're on a mission to enable every organization to make smarter decisions about tech. Whether it's finding a new game-changing vendor or understanding a new market, it's easier, faster and smarter with CB Insights. All made possible by the smartest, hardest-working team in tech. Subscribe to see more.

Expert Collections containing Truvian Sciences

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Truvian Sciences is included in 4 Expert Collections, including Medical Devices.

M

Medical Devices

8,637 items

Companies developing medical devices (per the IMDRF's definition of "medical device"). Includes software, lab-developed tests (LDTs), and combination products. *Columns updated as regularly as possible.

H

Health Monitoring & Diagnostics

3,095 items

Companies developing or offering products that aid in the assessment, screening, diagnosis, or monitoring of a person's state of health/wellness. Excludes companies focused solely on fitness/sports performance

D

Digital Health

13,075 items

Technologies, platforms, and systems that engage consumers for lifestyle, wellness, or health-related purposes; capture, store, or transmit health data; and/or support life science and clinical operations. (DiME, DTA, HealthXL, & NODE.Health)

H

Health IT

7,900 items

Truvian Sciences Patents

Truvian Sciences has filed 6 patents.

The 3 most popular patent topics include:

  • Blood tests
  • Hematology
  • Red blood cell disorders
patents chart

Application Date

Grant Date

Title

Related Topics

Status

5/18/2020

6/7/2022

Honeycombs (geometry), Physical oceanography, Technical drawing, 3D computer graphics, Subduction volcanoes

Grant

Application Date

5/18/2020

Grant Date

6/7/2022

Title

Related Topics

Honeycombs (geometry), Physical oceanography, Technical drawing, 3D computer graphics, Subduction volcanoes

Status

Grant

Latest Truvian Sciences News

Truvian Sciences President and CEO Jeff Hawkins to Speak Among Leaders of Nation’s Most Innovative Labs at The Dark Intelligence Group’s Executive War College Conference

Apr 27, 2022

April 27, 2022 08:00 AM Eastern Daylight Time NEW ORLEANS--( BUSINESS WIRE )--Truvian Sciences President and CEO Jeff Hawkins joins leaders of the nation’s most innovative labs to share new technologies and approaches to improve patient outcomes. WHAT:   General Session — Wednesday, April 27, 2022 at 11 a.m. Rethinking the Clinical Laboratory Test Value Chain: Using New Technologies and New Approaches to Lower Costs, Speed Time-to-Answer, and Contribute to Improved Patient Outcomes   General Session Panel — Wednesday, April 27, 2022 at 4:45 p.m. CDT Thinking Strategically: Spotting Opportunities Created by the Evolution of the Healthcare Value-Based Reimbursement, and New Technologies     About Truvian Sciences Truvian is a healthcare company at the intersection of diagnostics and consumer technology. Its automated benchtop system is being developed to produce lab-accurate results for a full-suite of health tests using a small sample of blood. Powered by patented technologies and intelligent integration, Truvian’s system delivers a convenient and affordable alternative to off-site labs, providing immediate insights to inform healthcare decisions. Truvian was founded by individuals with deep domain experience in healthcare, diagnostics, and consumer technology. Today, the team has expanded to include top scientists, engineers, and healthcare business leaders — each bringing specialized expertise to drive Truvian’s mission of making routine health testing convenient, affordable, and actionable. Contacts

Truvian Sciences Web Traffic

Rank
Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

Truvian Sciences Rank

  • When was Truvian Sciences founded?

    Truvian Sciences was founded in 2015.

  • Where is Truvian Sciences's headquarters?

    Truvian Sciences's headquarters is located at 10300 Campus Point Drive, Suite 190, San Diego.

  • What is Truvian Sciences's latest funding round?

    Truvian Sciences's latest funding round is Series C.

  • How much did Truvian Sciences raise?

    Truvian Sciences raised a total of $150.1M.

  • Who are the investors of Truvian Sciences?

    Investors of Truvian Sciences include DNS Capital, GreatPoint Ventures, General Catalyst, Wasson Enterprise, Wittington Ventures and 8 more.

  • Who are Truvian Sciences's competitors?

    Competitors of Truvian Sciences include Visby Medical, Baebies, Cardea Bio, MeMed, Accellix, Inflammatix, Oxford Nanopore Technologies, LumiraDx, Cue Health, Roche Holding and 24 more.

  • What products does Truvian Sciences offer?

    Truvian Sciences's products include We are not revealing the name yet and will call it our core technology for now and 1 more.

You May Also Like

S
Sight Diagnostics

Sight Diagnostics provides affordable and accurate diagnostics in a compact platform designed for use in qualified labs in low volume settings. Its proprietary machine-vision based technology provides the capability to perform multiple tests on a single, easy-to-operate platform.

BD Logo
BD

BD is a medical technology company that manufactures and sells a broad range of supplies, devices, and systems for use by healthcare professionals, medical research institutions, industry, and the general public.

D
DiaSorin

DiaSorin is a multinational biotechnology company that produces and markets in vitro diagnostics reagent kits used in immunodiagnostics and molecular diagnostics. It is based in Saluggia, Italy.

Hemex Health Logo
Hemex Health

Hemex creates affordable, life-changing medical diagnostics for under-served people everywhere. Its diagnostic platform is designed to reach populations at risk for malaria and sickle cell disease.

MeMed Logo
MeMed

MeMed is a med-tech and bio-convergence firm that researches, develops, and commercializes diagnostic host immune response testing methods that address complex clinical dilemmas and improve patient outcomes.

Weavr Health Logo
Weavr Health

Weavr Health is dedicated to connecting people to health by simplifying sample collection and processing for healthcare.The Velvet device is designed so anyone, anywhere can easily collect high-quality samples without a phlebotomist. The Velvet device offers a smooth experience of blood self-collection for patients. It leverages a similar experience to traditional glucose testing, which >25% of people have experienced. Each device arrives with all that is needed to collect, package and ship quality samples to the lab for a convenient experience.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.